Efficacy of topical tacrolimus monotherapy against pediatric discoid lupus erythematosus
Corresponding Author
Fumi Miyagawa
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Correspondence
Fumi Miyagawa, Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan.
Email: [email protected]
Search for more papers by this authorKohei Ogawa
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Search for more papers by this authorMinoru Hasegawa
Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
Search for more papers by this authorHideo Asada
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Search for more papers by this authorCorresponding Author
Fumi Miyagawa
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Correspondence
Fumi Miyagawa, Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan.
Email: [email protected]
Search for more papers by this authorKohei Ogawa
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Search for more papers by this authorMinoru Hasegawa
Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
Search for more papers by this authorHideo Asada
Department of Dermatology, Nara Medical University School of Medicine, Nara, Japan
Search for more papers by this author
REFERENCES
- 1Tzung TY, Liu YS, Chang HW. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol. 2007; 156: 191–192.
- 2Kuhn A, Gensch K, Haust M, Schneider SW, Bonsmann G, Gaebelein-Wissing N, et al. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol. 2011; 65: e1–e2.
- 3Pothinamthong P, Janjumratsang P. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index. J Med Assoc Thail. 2012; 95: 933–940.
- 4Wang X, Zhang L, Luo J, Wu Z, Mei Y, Wang Y, et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: a randomized, controlled clinical trial. J Clin Pharmacol. 2015; 55: 1221–1228.
- 5Kawachi Y, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, et al. Linear childhood discoid lupus erythematosus following the lines of Blaschko: successfully treated with topical tacrolimus. Pediatr Dermatol. 2011; 28: 205–207.
